Related Experiment Video
Updated: May 16, 2026
11:29
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention
Amy Anne D Lassig1, Matthew E Spector, Soheil Soliman
1Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota 55455, USA. donat037@umn.edu
Summary
Squamous cell carcinoma (SCCA) of the temporal bone shows 70% disease-free survival with lateral temporal bone resection. Tumor stage and facial nerve involvement significantly impact outcomes for this rare cancer.
Area of Science:
- Oncology
- Otorhinolaryngology
- Surgical Pathology
Background:
- Squamous cell carcinoma (SCCA) of the temporal bone is a rare malignancy.
- Understanding treatment efficacy and prognostic factors is crucial for patient management.
Purpose of the Study:
- To review treatment strategies and outcomes for temporal bone SCCA.
- To evaluate the effectiveness of lateral temporal bone resection.
Main Methods:
- Retrospective cohort study of 30 patients with temporal bone SCCA (1995-2011).
- Analysis of demographics, staging, surgical intervention (lateral temporal bone resection), adjuvant therapy, and survival.
- Disease-free survival was the primary outcome measure.
Main Results:
- Overall disease-free survival was 70%.
- Survival rates varied by tumor stage: T1 (100%), T2 (100%), T3 (67%), T4 (56%).
- Facial nerve (CN VII) resection was associated with diminished survival.
Conclusions:
- Lateral temporal bone resection offers comparable survival to more radical surgeries for temporal bone SCCA.
- Tumors originating from the external auditory canal and adjacent sites have similar prognoses.
- Facial nerve involvement is a negative prognostic indicator.
